Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed Nov 14, 2017 · 10-Q · 45 days after period end · 0001193125-17-341829
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Net Income | -$3.54M | -$3.24M | -$3.59M | -$3.45M |
| EPS Diluted | -$0.13 | -$0.12 | -$0.14 | -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Sep 30, 2017 · filed Nov 14, 2017 · 45 d after period end
